Demant A/S Unsponsored ADR (OTCMKTS:WILYY – Get Free Report) saw a large increase in short interest in May. As of May 15th, there was short interest totaling 87 shares, an increase of 141.7% from the April 30th total of 36 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 586 shares, the days-to-cover ratio is currently 0.1 days.
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group raised Demant A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, March 18th. Two research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy”.
Check Out Our Latest Stock Analysis on WILYY
Demant A/S Price Performance
About Demant A/S
Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.
Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.
Read More
- Five stocks we like better than Demant A/S
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.
